|Articles|May 1, 2017
EAG Laboratories
Advertisement
EAG Laboratories: Complete biopharmaceutical characterization services
EAG Laboratories’ complete suite of biopharmaceutical characterization services include: Mass analysis (intact, reduced, deglycosylated); Peptite Map-UPLC-UHR QT of MS (Sequencing, PTMs, Disulfide Linkages, Chemical Modification for ADC , PEG, etc.); N-Glycan Profile-UPLC-MS, HI LIC -FL (site, extent and structure of glycosylation); and Protein structure characterization, analysis of post-translational modifications and degradants, and glycosylation analysis.
+1.800.538.5227
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Insuring Novel Biologic Development Against Geopolitical Developments: Part Three of Three with Abzena
2
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
3
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
4
Top BP Videos of 2025: An Intersection of AI, Innovation, and Compliance
5